A new survey from Grant Thornton in the U.S. shows chief financial officers (CFOs) are accelerating technology investment even as economic confidence declines sharply. According to Grant Thornton’s Q2 ...

ABL Bio said on the 17th that Givastomig (ABL111), a bispecific immuno-oncology antibody it is co-developing with its U.S. partner Novabridge Biosciences (formerly i-Mab), has received fast track ...

and investors arising from the current dual use of "ABL" as the name of both the listed group entity and as the name of a customer-facing business segment.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ABL Diagnostics (FR001400AHX6 – “ABLD”) announces the signing of a multi-year contract with a European pharmaceutical company in the field of neurodegenerative diseases. The contract relates to ...